Depression and cardiac disease: epidemiology, mechanisms, and diagnosis

Jeff C Huffman1, Christopher M Celano, Scott R Beach

  • 1Harvard Medical School, Boston, MA 02114, USA ; Department of Psychiatry, Massachusetts General Hospital, Blake 11, 55 Fruit Street, Boston, MA 02114, USA.

Insights

Depression is common in cardiovascular disease (CVD) patients, worsening outcomes. Routine screening is recommended but often underutilized, necessitating better assessment strategies for this high-risk group.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depression is prevalent in cardiovascular disease (CVD) patients, significantly impacting quality of life, cardiac event recurrence, and mortality.
  • Physiological and behavioral factors link depression to adverse cardiac outcomes, highlighting a complex interplay.
  • Despite American Heart Association recommendations for routine screening using tools like the Patient Health Questionnaire, depression remains underrecognized and undertreated in CVD populations.

Purpose of the Study:

  • To review the epidemiology, phenomenology, comorbidities, and risk factors of depression in cardiac disease.
  • To outline the associations between depression and cardiac outcomes, including potential mediating mechanisms.
  • To discuss the evidence for and against routine depression screening in CVD patients and provide recommendations for assessment.

Main Methods:

  • Literature review on depression in cardiovascular disease.
  • Analysis of epidemiological data, clinical phenomenology, and risk factors.
  • Examination of proposed mechanisms linking depression to cardiac outcomes.
  • Evaluation of evidence supporting or refuting routine depression screening.

Main Results:

  • Depression is common in CVD, linked to poorer quality of life, increased cardiac events, and mortality.
  • Various physiological and behavioral pathways may mediate the relationship between depression and adverse cardiac events.
  • Despite screening recommendations and effective treatments, depression in CVD patients is frequently missed and inadequately managed.

Conclusions:

  • Depression poses a significant threat to patients with cardiovascular disease, affecting multiple health outcomes.
  • Routine depression screening in CVD patients is advised, yet current practices show underutilization.
  • Specific recommendations are needed for effective depression assessment and management in this vulnerable population to improve patient care and outcomes.

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...